Tandem Diabetes Care Debt to Equity Ratio 2012-2026 | TNDM
Current and historical debt to equity ratio values for Tandem Diabetes Care (TNDM) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Tandem Diabetes Care debt/equity for the three months ending March 31, 2026 was 2.00.
| Tandem Diabetes Care Debt/Equity Ratio Historical Data | |||
|---|---|---|---|
| Date | Long Term Debt | Shareholder's Equity | Debt to Equity Ratio |
| 2026-03-31 | $1.02B | $0.13B | 7.71 |
| 2025-12-31 | $0.73B | $0.16B | 4.68 |
| 2025-09-30 | $0.74B | $0.13B | 5.58 |
| 2025-06-30 | $0.74B | $0.13B | 5.57 |
| 2025-03-31 | $0.77B | $0.16B | 4.94 |
| 2024-12-31 | $0.71B | $0.26B | 2.68 |
| 2024-09-30 | $0.72B | $0.24B | 3.03 |
| 2024-06-30 | $0.70B | $0.23B | 3.01 |
| 2024-03-31 | $0.70B | $0.24B | 2.87 |
| 2023-12-31 | $0.64B | $0.31B | 2.04 |
| 2023-09-30 | $0.63B | $0.31B | 1.99 |
| 2023-06-30 | $0.62B | $0.33B | 1.88 |
| 2023-03-31 | $0.62B | $0.34B | 1.82 |
| 2022-12-31 | $0.61B | $0.44B | 1.39 |
| 2022-09-30 | $0.63B | $0.42B | 1.48 |
| 2022-06-30 | $0.59B | $0.45B | 1.31 |
| 2022-03-31 | $0.58B | $0.44B | 1.32 |
| 2021-12-31 | $0.47B | $0.43B | 1.09 |
| 2021-09-30 | $0.46B | $0.39B | 1.18 |
| 2021-06-30 | $0.45B | $0.35B | 1.30 |
| 2021-03-31 | $0.44B | $0.31B | 1.41 |
| 2020-12-31 | $0.35B | $0.37B | 0.96 |
| 2020-09-30 | $0.35B | $0.33B | 1.06 |
| 2020-06-30 | $0.35B | $0.27B | 1.30 |
| 2020-03-31 | $0.14B | $0.21B | 0.66 |
| 2019-12-31 | $0.13B | $0.20B | 0.67 |
| 2019-09-30 | $0.13B | $0.17B | 0.75 |
| 2019-06-30 | $0.11B | $0.15B | 0.76 |
| 2019-03-31 | $0.09B | $0.12B | 0.78 |
| 2018-12-31 | $0.08B | $0.13B | 0.57 |
| 2018-09-30 | $0.07B | $0.12B | 0.57 |
| 2018-06-30 | $0.13B | $0.03B | 5.08 |
| 2018-03-31 | $0.13B | $0.01B | 11.21 |
| 2017-12-31 | $0.12B | $-0.03B | -4.27 |
| 2017-09-30 | $0.12B | $-0.03B | -4.15 |
| 2017-06-30 | $0.12B | $-0.02B | -6.39 |
| 2017-03-31 | $0.12B | $0.00B | -61.34 |
| 2016-12-31 | $0.12B | $-0.01B | -19.96 |
| 2016-09-30 | $0.09B | $0.01B | 16.38 |
| 2016-06-30 | $0.08B | $0.03B | 2.40 |
| 2016-03-31 | $0.08B | $0.05B | 1.63 |
| 2015-12-31 | $0.06B | $0.06B | 0.97 |
| 2015-09-30 | $0.06B | $0.07B | 0.80 |
| 2015-06-30 | $0.05B | $0.09B | 0.61 |
| 2015-03-31 | $0.05B | $0.10B | 0.52 |
| 2014-12-31 | $0.05B | $0.06B | 0.95 |
| 2014-09-30 | $0.05B | $0.07B | 0.73 |
| 2014-06-30 | $0.05B | $0.08B | 0.56 |
| 2014-03-31 | $0.05B | $0.10B | 0.46 |
| 2013-12-31 | $0.05B | $0.12B | 0.40 |
| 2013-09-30 | $0.05B | $0.00B | -18.28 |
| 2013-06-30 | $0.05B | $0.01B | 5.47 |
| 2013-03-31 | $0.00B | $0.00B | 0.00 |
| 2012-12-31 | $0.00B | 0.00 | |
| 2012-09-30 | $0.00B | $0.00B | 0.00 |
| 2012-06-30 | $0.00B | $0.00B | 0.00 |
| 2011-12-31 | $0.02B | $0.00B | -5.15 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $1.314B | $1.015B |
| Tandem Diabetes Care, Inc. designs, develops and markets products for people with insulin-dependent diabetes. The company's flagship product, the t:slim X2 Insulin Delivery System, or t:slim X2, is based on its proprietary technology platform. Per the company, t:slim X2 is the smallest durable insulin pump available and is also the only available pump capable of remote feature updates.Tandem Diabetes also offers t:flex insulin delivery system which includes t:flex pump, its 480-unit disposable insulin cartridge, an infusion set, t:lock cartridge and infusion set products, various pump accessories along with t:slim X2 with G5 integration. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $184.365B | 21.69 |
| Intuitive Surgical (ISRG) | United States | $160.029B | 61.73 |
| Edwards Lifesciences (EW) | United States | $44.895B | 30.42 |
| IDEXX Laboratories (IDXX) | United States | $44.716B | 43.08 |
| Alcon (ALC) | Switzerland | $38.585B | 25.49 |
| Waters (WAT) | United States | $31.413B | 24.37 |
| IQVIA Holdings (IQV) | United States | $28.398B | 15.40 |
| Mettler-Toledo (MTD) | United States | $26.829B | 30.97 |
| DexCom (DXCM) | United States | $24.639B | 30.63 |
| STERIS (STE) | Ireland | $21.830B | 22.08 |
| Hologic (HOLX) | United States | $16.752B | 17.53 |
| Coloplast (CLPBY) | Denmark | $15.055B | 23.03 |
| SONOVA HOLDING (SONVY) | Switzerland | $13.774B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $13.199B | 9.72 |
| Penumbra (PEN) | United States | $12.941B | 85.88 |
| Globus Medical (GMED) | United States | $12.230B | 22.60 |
| Masimo (MASI) | United States | $9.578B | 30.69 |
| Glaukos (GKOS) | United States | $6.760B | 0.00 |
| SARTORIUS (SSSGY) | Germany | $6.754B | 39.22 |
| Sysmex ADR (SSMXY) | Japan | $5.470B | 18.10 |
| Teleflex (TFX) | United States | $5.233B | 9.67 |
| TransMedics (TMDX) | United States | $3.910B | 40.00 |
| LivaNova (LIVN) | United Kingdom | $3.433B | 18.41 |
| Integer Holdings (ITGR) | United States | $2.900B | 13.28 |
| Veracyte (VCYT) | United States | $2.470B | 24.48 |
| Elekta AB (EKTAY) | Sweden | $2.226B | 20.13 |
| Artivion (AORT) | United States | $1.825B | 59.73 |
| AxoGen (AXGN) | United States | $1.659B | 0.00 |
| Alphatec Holdings (ATEC) | United States | $1.650B | 0.00 |
| Nihon Kohden (NHNKY) | Japan | $1.642B | 18.12 |
| UFP Technologies (UFPT) | United States | $1.552B | 20.54 |
| PROCEPT BioRobotics (PRCT) | United States | $1.308B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $1.269B | 0.00 |
| IRadimed (IRMD) | United States | $1.194B | 53.37 |
| OPKO Health (OPK) | United States | $0.881B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $0.772B | 4.44 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.659B | 15.09 |
| Alpha Tau Medical (DRTS) | Israel | $0.618B | 0.00 |
| SiBone (SIBN) | United States | $0.567B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.552B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.533B | 28.23 |
| Mesa Laboratories (MLAB) | United States | $0.530B | 13.79 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.497B | 0.00 |
| NeuroPace (NPCE) | United States | $0.480B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.405B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.405B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.404B | 0.00 |
| Beta Bionics (BBNX) | United States | $0.393B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.346B | 143.43 |
| Semler Scientific (SMLR) | United States | $0.311B | 2.32 |
| Spectral Diagnostics (EDTXF) | Canada | $0.296B | 0.00 |
| RxSight (RXST) | United States | $0.282B | 0.00 |
| 908 Devices (MASS) | United States | $0.267B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.257B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.203B | 0.00 |
| CVRx (CVRX) | United States | $0.188B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.186B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.174B | 0.00 |
| Inogen (INGN) | United States | $0.172B | 0.00 |
| Nano-X Imaging (NNOX) | Israel | $0.148B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.124B | 0.00 |
| Hyperfine (HYPR) | United States | $0.119B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.117B | 0.00 |
| Zomedica (ZOMDF) | United States | $0.111B | 0.00 |
| Solana (HSDT) | United States | $0.104B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.096B | 0.00 |
| Neuronetics (STIM) | United States | $0.094B | 0.00 |
| QT Imaging Holdings (QTI) | United States | $0.083B | 0.00 |
| QT Imaging Holdings (QTIH) | United States | $0.078B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.074B | 0.00 |
| LENSAR (LNSR) | United States | $0.069B | 0.00 |
| Positron (POSC) | United States | $0.062B | 0.00 |
| InspireMD (NSPR) | United States | $0.060B | 0.00 |
| Spectral AI (MDAI) | United States | $0.055B | 0.00 |
| DarioHealth (DRIO) | United States | $0.053B | 0.00 |
| Envoy Medical (COCH) | United States | $0.047B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.047B | 0.00 | |
| Accuray (ARAY) | United States | $0.046B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.043B | 0.00 |
| Precision Optics (POCI) | United States | $0.032B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.032B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.028B | 0.00 |
| Check-Cap (MBAI) | Israel | $0.012B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.011B | 0.00 |
| PAVmed (PAVM) | United States | $0.009B | 0.00 |
| Tenon Medical (TNON) | United States | $0.009B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.007B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.006B | 0.00 |
| NexGel (NXGL) | United States | $0.005B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.004B | 0.00 |
| Nuwellis (NUWE) | United States | $0.003B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.003B | 0.00 |
| ENvue Medical (FEED) | United States | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.000B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |